Business
Dianthus Therapeutics CFO Sells $9.5 Million in Stock
April 6, 2026
The Motley Fool
Scroll
This biotech firm developing antibody therapies for rare diseases disclosed a significant insider sale amid rapid share price gains.
The Motley Fool
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left